A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

NCT06076642 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immunodeficiency Diseases (PID)

Interventions

BIOLOGICAL: TAK-881
DEVICE: Koru 24 G HIgH Flo Subcutaneous Safety Needle Set (investigational in the US)

Sponsor

Takeda

Collaborators

[object Object]
[object Object]